Sign up to save your podcasts
Or
Share Shots-on-Goal Licensing Company Aims for Breakthroughs
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Shots-on-Goal Licensing Company Aims for Breakthroughs
A very special breed of animals is helping biotech and pharma companies in the quest for new human therapeutics. CFO Kurt Gustafson joins Pathfinders in Biopharma to explain the technologies behind OmniAb’s business model.
View all episodes
By RBC Capital Markets
5
1212 ratings
A very special breed of animals is helping biotech and pharma companies in the quest for new human therapeutics. CFO Kurt Gustafson joins Pathfinders in Biopharma to explain the technologies behind OmniAb’s business model.
More shows like Pathfinders in Biopharma
View all
Motley Fool Hidden Gems Investing
3,220 Listeners
WSJ Your Money Briefing
1,721 Listeners
Exchanges
973 Listeners
Odd Lots
1,968 Listeners
WSJ Tech News Briefing
1,657 Listeners
The a16z Show
1,095 Listeners
The Long Run with Luke Timmerman
124 Listeners
The Readout Loud
337 Listeners
Wall Street Breakfast
1,038 Listeners
Thoughts on the Market
1,303 Listeners
The Journal.
6,091 Listeners
BioCentury This Week
34 Listeners
RBC's Markets in Motion
43 Listeners
Biotech Hangout
23 Listeners
Industries in Motion
10 Listeners
Powering Sustainable Ideas
0 Listeners
The Markets
80 Listeners
Strategic Alternatives
19 Listeners
The Top Line
15 Listeners
Macro Minutes
3 Listeners